Brian R D'urso

This inventor holds 11 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ut-Battelle, Inc., The University of Tennessee Research Foundation. Active years: 2006-2015.

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 54.5

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 249(Granted Patents)

Company Filing History:

The University of Tennessee Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2006-2015

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9044299 - Microfabricated instruments and methods to treat recurrent corneal erosions (2015-06-02),

2. 8591481 - Microfabricated instruments and methods to treat recurrent corneal erosion (2013-11-26),

3. 8425596 - Retinal instrument (2013-04-23),

4. 8241508 - Method of forming composite, ordered material having sharp surface features (2012-08-14),

5. 8216674 - Superhydrophobic diatomaceous earth (2012-07-10),

6. 7707854 - Method of producing microchannel and nanochannel articles (2010-05-04),

7. 7697808 - Multi-tipped optical component (2010-04-13),

8. 7697807 - Multi-tipped optical component (2010-04-13),

9. 7638182 - Method for producing microchannels in drawn material (2009-12-29),

10. 7258731 - Composite, nanostructured, super-hydrophobic material (2007-08-21),

11. 7150904 - Composite, ordered material having sharp surface features (2006-12-19),

Brian R. D'urso: Pioneering Innovations in Ophthalmology Treatment

Brian R. D'urso is a renowned inventor and founder in the medical devices industry, with 10 patents to his name. He hails from Clinton, TN (US), and has made remarkable contributions to ophthalmology treatment.

His latest patents include microfabricated instruments and methods to treat recurrent corneal erosions - which provide a device and method for treating recurrent corneal erosion. This method involves contacting an epithelium layer of a cornea with an array of glass micro-rods. The plurality of punctures in the Bowman's layer of the eye produced by the array of glass micro-rods are of a micro-scale or less. Additionally, the present invention provides a method and device for drug delivery through an array of glass micro-rods.

D'urso has worked in prominent companies such as UT-Battelle, Inc. and the UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION. He has collaborated with esteemed professionals such as John T. Simpson, among others.

Through his expertise and innovation, D'urso has revolutionized ophthalmology treatment, especially for patients with recurrent corneal erosion. The invention provides a less invasive and more effective approach for delivering drugs and treating conditions. It is safe to say that we can expect more exciting things coming from this talented inventor.